Track the Alaunos Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Alaunos Therapeutics, Inc. has recorded 37 insider filings. Market capitalisation: €4.9m. The latest transaction was reported on 11 August 2026 (Attribution). Among the most active insiders: Postma Robert W. All data is accessible without an account.
37
Insider Decl.
n/a
Thresholds
€1m
2 ops.
Buy Volume
€13,014
2 ops.
Sell Volume
38Σ signal
Buys €1m€13,014 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
68,014 shares@ US$0.140316.3% of flowCommon StockSEC:0000950170-23-046504:0
25 of 37 declarations
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It utilizes innovative technology to create personalized treatments for patients.